Concepts (159)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Tissue Scaffolds | 8 | 2016 | 421 | 1.030 |
Why?
|
| Tissue Engineering | 7 | 2019 | 659 | 0.960 |
Why?
|
| Myocytes, Smooth Muscle | 2 | 2016 | 72 | 0.590 |
Why?
|
| Polyesters | 2 | 2016 | 78 | 0.520 |
Why?
|
| Collagen | 3 | 2019 | 219 | 0.520 |
Why?
|
| Biomimetic Materials | 1 | 2016 | 15 | 0.510 |
Why?
|
| Hydrogels | 2 | 2019 | 126 | 0.510 |
Why?
|
| Stem Cells | 3 | 2016 | 314 | 0.500 |
Why?
|
| Urothelium | 1 | 2016 | 55 | 0.500 |
Why?
|
| Suburethral Slings | 1 | 2016 | 14 | 0.490 |
Why?
|
| Myoblasts | 1 | 2016 | 37 | 0.480 |
Why?
|
| Urethra | 1 | 2016 | 100 | 0.470 |
Why?
|
| Urinary Incontinence | 1 | 2016 | 48 | 0.470 |
Why?
|
| Nanoparticles | 1 | 2016 | 56 | 0.460 |
Why?
|
| Placenta | 1 | 2016 | 75 | 0.460 |
Why?
|
| Urinary Bladder | 4 | 2012 | 183 | 0.430 |
Why?
|
| Stem Cell Transplantation | 1 | 2016 | 212 | 0.430 |
Why?
|
| Penile Erection | 2 | 2009 | 21 | 0.320 |
Why?
|
| Penis | 2 | 2009 | 35 | 0.310 |
Why?
|
| Impotence, Vasculogenic | 1 | 2009 | 1 | 0.310 |
Why?
|
| Phosphodiesterase Inhibitors | 1 | 2009 | 8 | 0.310 |
Why?
|
| Vasodilator Agents | 1 | 2009 | 59 | 0.300 |
Why?
|
| Animals | 16 | 2019 | 7569 | 0.300 |
Why?
|
| Rabbits | 3 | 2016 | 192 | 0.270 |
Why?
|
| Wound Healing | 2 | 2019 | 188 | 0.220 |
Why?
|
| Aging | 1 | 2010 | 938 | 0.210 |
Why?
|
| Endothelial Cells | 3 | 2013 | 197 | 0.200 |
Why?
|
| Rats | 7 | 2012 | 1606 | 0.190 |
Why?
|
| Diabetes Mellitus, Experimental | 3 | 2007 | 57 | 0.180 |
Why?
|
| Cell Proliferation | 4 | 2019 | 602 | 0.170 |
Why?
|
| Muscle, Smooth | 2 | 2010 | 69 | 0.150 |
Why?
|
| Cell Shape | 2 | 2016 | 28 | 0.150 |
Why?
|
| Erectile Dysfunction | 3 | 2008 | 50 | 0.150 |
Why?
|
| Large-Conductance Calcium-Activated Potassium Channel alpha Subunits | 2 | 2008 | 5 | 0.140 |
Why?
|
| Cell Line | 2 | 2016 | 433 | 0.130 |
Why?
|
| Muscle, Skeletal | 2 | 2012 | 524 | 0.130 |
Why?
|
| Skin | 1 | 2019 | 214 | 0.130 |
Why?
|
| Sus scrofa | 3 | 2014 | 47 | 0.130 |
Why?
|
| Materials Testing | 1 | 2016 | 92 | 0.120 |
Why?
|
| Cell Differentiation | 2 | 2016 | 467 | 0.120 |
Why?
|
| Nanofibers | 1 | 2016 | 7 | 0.120 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2016 | 90 | 0.120 |
Why?
|
| Staining and Labeling | 1 | 2016 | 57 | 0.120 |
Why?
|
| Mechanical Phenomena | 1 | 2016 | 28 | 0.120 |
Why?
|
| Endothelium, Vascular | 2 | 2014 | 155 | 0.120 |
Why?
|
| Prosthesis Implantation | 2 | 2014 | 39 | 0.120 |
Why?
|
| Male | 9 | 2016 | 19641 | 0.120 |
Why?
|
| Blotting, Western | 1 | 2016 | 287 | 0.120 |
Why?
|
| Rats, Inbred F344 | 3 | 2010 | 134 | 0.110 |
Why?
|
| RNA, Messenger | 1 | 2016 | 498 | 0.110 |
Why?
|
| Bioengineering | 1 | 2014 | 68 | 0.110 |
Why?
|
| Extracellular Matrix | 1 | 2016 | 243 | 0.110 |
Why?
|
| Cell-Derived Microparticles | 1 | 2013 | 6 | 0.100 |
Why?
|
| Liver Transplantation | 1 | 2014 | 183 | 0.100 |
Why?
|
| Recovery of Function | 2 | 2012 | 203 | 0.100 |
Why?
|
| Erythrocytes | 1 | 2013 | 48 | 0.100 |
Why?
|
| Nitric Oxide | 1 | 2013 | 111 | 0.100 |
Why?
|
| Pregnancy | 1 | 2016 | 981 | 0.100 |
Why?
|
| Printing | 1 | 2012 | 5 | 0.100 |
Why?
|
| Ink | 1 | 2012 | 11 | 0.100 |
Why?
|
| Cartilage | 1 | 2012 | 31 | 0.100 |
Why?
|
| Mice, Nude | 4 | 2019 | 290 | 0.100 |
Why?
|
| Mice | 6 | 2019 | 2511 | 0.090 |
Why?
|
| Electric Stimulation | 2 | 2010 | 106 | 0.090 |
Why?
|
| Muscular Diseases | 1 | 2012 | 23 | 0.090 |
Why?
|
| Immunohistochemistry | 1 | 2013 | 497 | 0.090 |
Why?
|
| Liver | 1 | 2014 | 492 | 0.090 |
Why?
|
| Cell Culture Techniques | 1 | 2012 | 172 | 0.090 |
Why?
|
| Transfection | 2 | 2009 | 184 | 0.090 |
Why?
|
| Biocompatible Materials | 1 | 2012 | 233 | 0.090 |
Why?
|
| Transducers, Pressure | 1 | 2010 | 1 | 0.080 |
Why?
|
| Carbachol | 1 | 2010 | 5 | 0.080 |
Why?
|
| Urinary Catheterization | 1 | 2010 | 16 | 0.080 |
Why?
|
| Signal Processing, Computer-Assisted | 1 | 2010 | 39 | 0.080 |
Why?
|
| Statistics, Nonparametric | 1 | 2010 | 126 | 0.080 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2009 | 754 | 0.080 |
Why?
|
| Female | 7 | 2019 | 20261 | 0.080 |
Why?
|
| Sexual Behavior, Animal | 1 | 2008 | 8 | 0.070 |
Why?
|
| Statistics as Topic | 1 | 2009 | 104 | 0.070 |
Why?
|
| Gene Transfer Techniques | 1 | 2009 | 65 | 0.070 |
Why?
|
| Models, Animal | 1 | 2009 | 171 | 0.070 |
Why?
|
| Membrane Glycoproteins | 1 | 2009 | 98 | 0.070 |
Why?
|
| Logistic Models | 1 | 2010 | 783 | 0.070 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2013 | 1307 | 0.070 |
Why?
|
| Aldehyde Reductase | 1 | 2007 | 3 | 0.070 |
Why?
|
| Membrane Proteins | 1 | 2009 | 251 | 0.070 |
Why?
|
| Alternative Splicing | 1 | 2006 | 32 | 0.060 |
Why?
|
| Neural Conduction | 1 | 2007 | 89 | 0.060 |
Why?
|
| Urinary Bladder Diseases | 1 | 2006 | 20 | 0.060 |
Why?
|
| Age Factors | 1 | 2009 | 1197 | 0.060 |
Why?
|
| Diabetes Complications | 1 | 2006 | 182 | 0.060 |
Why?
|
| Humans | 6 | 2019 | 32798 | 0.050 |
Why?
|
| Atherosclerosis | 1 | 2008 | 788 | 0.050 |
Why?
|
| Risk Factors | 1 | 2010 | 3974 | 0.050 |
Why?
|
| Cell Survival | 2 | 2012 | 280 | 0.040 |
Why?
|
| Keratinocytes | 1 | 2019 | 29 | 0.040 |
Why?
|
| Skin, Artificial | 1 | 2019 | 33 | 0.040 |
Why?
|
| Equipment Design | 1 | 2019 | 179 | 0.040 |
Why?
|
| Fibroblasts | 1 | 2019 | 114 | 0.040 |
Why?
|
| Swine | 1 | 2019 | 216 | 0.040 |
Why?
|
| Cells, Cultured | 2 | 2011 | 820 | 0.030 |
Why?
|
| Urination | 2 | 2007 | 16 | 0.030 |
Why?
|
| Vascular Patency | 1 | 2014 | 70 | 0.030 |
Why?
|
| Mannitol | 1 | 2013 | 1 | 0.030 |
Why?
|
| Endothelium-Dependent Relaxing Factors | 1 | 2013 | 2 | 0.030 |
Why?
|
| Cholinergic Antagonists | 1 | 2013 | 10 | 0.030 |
Why?
|
| Oxyhemoglobins | 1 | 2013 | 7 | 0.030 |
Why?
|
| Biological Availability | 1 | 2013 | 21 | 0.030 |
Why?
|
| Sodium Chloride | 1 | 2013 | 21 | 0.030 |
Why?
|
| Adenine | 1 | 2013 | 16 | 0.030 |
Why?
|
| Hemoglobins | 1 | 2013 | 49 | 0.030 |
Why?
|
| Acetylcholine | 1 | 2013 | 48 | 0.030 |
Why?
|
| Blood Transfusion | 1 | 2013 | 76 | 0.020 |
Why?
|
| Vasodilation | 1 | 2013 | 92 | 0.020 |
Why?
|
| Intracellular Space | 1 | 2012 | 16 | 0.020 |
Why?
|
| Implants, Experimental | 1 | 2012 | 12 | 0.020 |
Why?
|
| Electrophysiological Phenomena | 1 | 2012 | 26 | 0.020 |
Why?
|
| X-Ray Microtomography | 1 | 2012 | 41 | 0.020 |
Why?
|
| Microscopy, Fluorescence | 1 | 2012 | 91 | 0.020 |
Why?
|
| Cattle | 1 | 2012 | 108 | 0.020 |
Why?
|
| Dogs | 1 | 2012 | 120 | 0.020 |
Why?
|
| Polymers | 1 | 2012 | 66 | 0.020 |
Why?
|
| PAX7 Transcription Factor | 1 | 2012 | 8 | 0.020 |
Why?
|
| Isometric Contraction | 1 | 2012 | 23 | 0.020 |
Why?
|
| Glucose | 1 | 2013 | 184 | 0.020 |
Why?
|
| Calcium Signaling | 1 | 2012 | 46 | 0.020 |
Why?
|
| Osteogenesis | 1 | 2012 | 81 | 0.020 |
Why?
|
| Chondrocytes | 1 | 2012 | 69 | 0.020 |
Why?
|
| Amniotic Fluid | 1 | 2012 | 86 | 0.020 |
Why?
|
| Rats, Inbred Lew | 1 | 2012 | 120 | 0.020 |
Why?
|
| Neovascularization, Physiologic | 1 | 2012 | 111 | 0.020 |
Why?
|
| Immunochemistry | 1 | 2011 | 8 | 0.020 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 2011 | 94 | 0.020 |
Why?
|
| Regeneration | 1 | 2012 | 170 | 0.020 |
Why?
|
| Phenotype | 1 | 2012 | 638 | 0.020 |
Why?
|
| Electrophoresis, Agar Gel | 1 | 2009 | 14 | 0.020 |
Why?
|
| Electroporation | 1 | 2009 | 14 | 0.020 |
Why?
|
| Gels | 1 | 2009 | 32 | 0.020 |
Why?
|
| Plasmids | 1 | 2009 | 45 | 0.020 |
Why?
|
| Liposomes | 1 | 2009 | 30 | 0.020 |
Why?
|
| Green Fluorescent Proteins | 1 | 2009 | 72 | 0.020 |
Why?
|
| Models, Genetic | 1 | 2009 | 94 | 0.020 |
Why?
|
| Transplantation, Heterologous | 1 | 2009 | 122 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2012 | 1012 | 0.020 |
Why?
|
| Aorta | 1 | 2009 | 127 | 0.020 |
Why?
|
| Feasibility Studies | 1 | 2009 | 308 | 0.020 |
Why?
|
| Mice, Knockout | 1 | 2009 | 453 | 0.020 |
Why?
|
| Imidazolidines | 1 | 2007 | 1 | 0.020 |
Why?
|
| Macaca fascicularis | 1 | 2008 | 431 | 0.020 |
Why?
|
| Hyperglycemia | 1 | 2007 | 81 | 0.020 |
Why?
|
| Base Sequence | 1 | 2006 | 247 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2006 | 255 | 0.020 |
Why?
|
| Molecular Sequence Data | 1 | 2006 | 352 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2007 | 459 | 0.020 |
Why?
|
| Organ Size | 1 | 2006 | 219 | 0.010 |
Why?
|
| Hypoglycemic Agents | 1 | 2006 | 180 | 0.010 |
Why?
|
| Insulin | 1 | 2006 | 367 | 0.010 |
Why?
|
| Blood Glucose | 1 | 2006 | 494 | 0.010 |
Why?
|
| Kidney | 1 | 2006 | 520 | 0.010 |
Why?
|